MetaADEDB 2.0 @ LMMD
Dibucaine
(PUFQVTATUTYEAL-UHFFFAOYSA-N)
Structure
SMILES
CCCCOc1nc2ccccc2c(c1)C(=O)NCCN(CC)CC
Type(s)
Approved; Vet_approved
ATC code(s)
C05AD04; D04AB02; N01BB06; S01HA06; S02DA04
Molecular Formula:
C20H29N3O2
Molecular Weight:
343.463
Log P:
3.8762
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
54.46
CAS Number(s):
85-79-0
Synonym(s)
1.
Dibucaine
2.
Cincain
3.
Cinchocaine
4.
Nupercainal
5.
Nupercaine
6.
Sovcaine
External Link(s)
MeSHD003992
PubChem Compound3025
BindingDB48532
ChEBI247956
CHEMBLCHEMBL1086
DrugBankDB00527
DrugCentral859
IUPHAR/BPS Guide to PHARMACOLOGY7159
KEGGcpd:C07879
dr:D00733
Therapeutic Target DatabaseD0P5GE
ZINC1530939
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 6
Canada Vigilance: 1		Canada Vigilance
US FAERS
2Product quality issueFAERS: 5US FAERS
3Back PainFAERS: 2US FAERS
4Compression fractureFAERS: 2US FAERS
5Incorrect drug administration durationFAERS: 2US FAERS
6Incorrect route of drug administrationFAERS: 2US FAERS
7OverdoseFAERS: 2US FAERS
8SinusitisFAERS: 2US FAERS
9Therapeutic response unexpectedFAERS: 2US FAERS
10Accidental drug intake by childFAERS: 1US FAERS
11Atrioventricular BlockFAERS: 119834416CTD
US FAERS
12Blood glucose increasedFAERS: 1US FAERS
13BradycardiaFAERS: 119834416CTD
US FAERS
14DisabilityFAERS: 1US FAERS
15Disease recurrenceFAERS: 1US FAERS
16DizzinessFAERS: 1US FAERS
17Drug toxicityFAERS: 1US FAERS
18General physical health deteriorationFAERS: 1US FAERS
19HypersensitivityFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
20HypotensionFAERS: 15090228
12439553		CTD
US FAERS
21HysterectomyFAERS: 1US FAERS
22Impaired work abilityFAERS: 1US FAERS
23Intestinal ObstructionFAERS: 1US FAERS
24Mass excisionFAERS: 1US FAERS
25Maternal exposure during pregnancyFAERS: 1US FAERS
26Medication ErrorFAERS: 1US FAERS
27PainFAERS: 112481453CTD
US FAERS
28PruritusFAERS: 1US FAERS
29Visual ImpairmentFAERS: 1US FAERS
30Application site reactionCanada Vigilance: 1Canada Vigilance
31Headache5090228CTD
32Lysosomal Storage Diseases28551711CTD
33Polyradiculopathy15160665CTD
34Rash erythematousCanada Vigilance: 1Canada Vigilance
35Seizures19834416CTD
36Tachycardia, Ventricular19834416CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.